Ungbae Jeon

Title: Innovations of Ungbae Jeon in Viral Embolization

Introduction

Ungbae Jeon is a notable inventor based in Busan, South Korea. He has made significant contributions to the field of medical technology, particularly in the area of viral embolization. His work focuses on utilizing oncolytic viruses for therapeutic purposes, which has the potential to revolutionize cancer treatment.

Latest Patents

Ungbae Jeon holds 1 patent for his invention titled "Compositions and methods for viral embolization." This patent describes the use of oncolytic viruses in transcatheter arterial viroembolization methods. The invention also includes compositions that combine these viruses with biocompatible microparticles or hydrophilic polymer gel agents, which are suitable for active embolization. The methods outlined in the patent aim to effectively debulk tumors, showcasing the innovative approach Jeon has taken in cancer therapy.

Career Highlights

Jeon is associated with Sillajen, Inc., a company that focuses on developing innovative cancer therapies. His work at Sillajen has allowed him to explore the potential of oncolytic viruses in clinical applications. His dedication to advancing medical technology is evident in his research and patent contributions.

Collaborations

Ungbae Jeon has collaborated with notable colleagues, including Tae Ho Hwang and Nam Hee Lee. These partnerships have likely enhanced the development and application of his innovative ideas in the field of viral embolization.

Conclusion

Ungbae Jeon's contributions to the field of viral embolization represent a significant advancement in cancer treatment methodologies. His innovative approach and dedication to research continue to inspire progress in medical technology.